High Throughput Screening (HTS) Market size to grow by USD 19.9 billion from 2023 to 2028; North America to account for 40% of market growth- Technavio

07 Nov 2023
www.prnewswire.com
NEW YORK, Nov. 7, 2023 /PRNewswire/ -- The
high throughput screening (HTS) market is expected to grow by
USD 19.9 billion from 2023 to 2028. In addition, the market's momentum will progress at a
CAGR of 12.12% during the forecast period, according to Technavio Research. The market has been segmented by Application (Target identification and validation, Primary and secondary screening, Toxicology assessment, and Stem cell research), End-user (Pharmaceutical and biotechnology companies, Academic and research institutes, and CROs), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
North America is estimated to contribute
40% to the growth of the global market during the forecast period. This growth is driven by the presence of key players that are constantly supporting an increasing number of pharmaceutical and biotechnology companies in this region through a diversified HTS portfolio, including BioRad Laboratories and Thermo Fisher Scientific.
This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report
Continue Reading
High Throughput Screening (HTS) Market size to grow by USD 19.9 billion from 2023 to 2028; North America to account for 40% of market growth- Technavio
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global High Throughput Screening (HTS) Market 2024-2028
Company Profile:
Agilent Technologies Inc. - The company offers high throughput screening products such as the Agilent RapidFire 400 high throughput mass spectrometry system.
To access more company profiles available with Technavio, buy the report!
High Throughput Screening (HTS) Market: Segmentation Analysis
The market share growth by the
target identification and validation segment will be significant during the forecast period. The growth of this segment will be enhanced by the progress made in identifying and validating new drug targets based on various approaches.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio
High Throughput Screening (HTS) Market: Market Dynamics
Rise in R and D investments
Increasing prevalence of chronic diseases
Patent expiration of drugs
Key Driver
The increasing prevalence of chronic diseases is the key factor driving market growth.  HTS plays an important role in the discovery process, providing valuable information and saving time and money which is expected to help drive a market for highthroughput screening.
Major Trend
Increasing focus on promotional activities is the primary trend shaping market growth. Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information.
Related Reports:
The
Life Sciences Analytics Market size is estimated to grow by USD 7,830.57 million at a CAGR of 12.02% between 2023 and 2028.
The
cell surface markers market size is estimated to grow by USD 14,068.95 million at a CAGR of 8.25% between 2023 and 2028.
What are the key data covered in this high throughput screening (HTS) market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the high throughput screening (HTS) market between 2023 and 2028.
Precise estimation of the high throughput screening (HTS) market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the high throughput screening (HTS) market across North America, Europe, Asia, and ROW
A thorough analysis of the market's competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of high throughput screening (HTS) market companies.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by End-User
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.